摘要
Cancer-associated lymphatic endothelial cells (LECs) are an active barrier to the effector arm of the anti-tumor immune response; however, it remains unclear how LECs become immunosuppressive in the tumor microenvironment (TME). Exosomal microRNAs (miRNAs) have recently been implicated in intercellular crosstalk within the TME. Here, we report a mechanistic model via which cervical cancer-secreted, exosome-encapsulated microRNA (miR)-1468-5p promotes lymphatic PD-L1 upregulation and lymphangiogenesis to impair T cell immunity. Subsequently, exosomal miR-1468-5p epigenetically activates the JAK2/STAT3 pathway in LECs by directly targeting homeobox containing 1 (HMBOX1) in the SOCS1 promoter, activating an immunosuppressive program that allows cancer cells to escape anti-cancer immunity. Furthermore, clinical data reveal that high serum exosomal miR-1468-5p levels correlate with TME immunosuppressive status and poor prognosis in cervical cancer (CCa) patients. Taken together, our results suggest that cancer-secreted exosomal miR-1468-5p instructs LECs to form an integrated immunosuppressive TME component and may be a prognostic biomarker and therapeutic target for CCa.
学科与关键词
- Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironmentZhou, Chenfei; Zhang, Yanmei; Yan, Ruiming; Huang, Lei; Mellor, Andrew L.; Yang, Yang; Chen, Xiaojing; Wei, Wenfei; Wu, Xiangguang; Yu, Lan; Liang, Luojiao; Zhang, Dan; Wu, Sha*; Wang, Wei*Cell Death and Differentiation, 2021, 28(2): 715-729.被引 54
- Nasopharyngeal cancer cell-derived exosomal PD-L1 inhibits CD8+T-cell activity and promotes immune escapeYang, Jie; Chen, Jierong; Liang, Hu; Yu, Yahui*Cancer Science, 2022, 113(9): 3044-3054.被引 15
- Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1He, Qinglian; Ye, Aihua; Ye, Weibiao; Liao, Xiaomin; Qin, Guoqiang; Xu, Yongqiang; Yin, Yuting; Luo, Huanqian; Yi, Muhua; Xian, Liying; Zhang, Shihao; Qin, Xiyuan; Zhu, Wei*; Li, Yuling*Cell Death & Disease, 2021, 12(6): 576.被引 63
